Acadia Pharmaceuticals | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
ALKERMES USD 257.31M 110.81M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Corcept Therapeutics USD 178.93M 745K 2024-12
Cytokinetics -160545000 81.19M 2024-09
Eisai JPY 170.21B 16.72B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Incyte USD 985.09M 111.22M 2025-03
J&J USD 14.6B 816M 2025-03
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Pfizer USD 11.12B 987M 2025-03
Prothena -59001000 66.45M 2024-09
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Acadia Pharmaceuticals Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.